| Company Name: | Amerigroup Corporation | | Ticker Symbol: | AGP | | | WWW Address: | www.realsolutions.com |
| CEO: | Mr. James G. Carlson | | No. of Employees: | 5,100 |
| Common Issue Type: | CS | | Business Description: | Amerigroup Corporation focuses on serving people who receive healthcare benefits through publicly sponsored programs, including Medicaid, Children's Health Insurance Program, Medicaid expansion programs and Medicare Advantage.
|
| | | Industry Information: | HEALTH SERVICES - Health Care Plans [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 91.87 |  0.0 | - | - | | 91.70 | 91.70 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 4,704.5 | 51.2 | 1.08 | 3.82 | 0.00 | 35.7 | 0.0 | 91.97 - 56.41 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 91.70 | $ | | PE Ratio - LTM | 35.7 | |
| Market Capitalisation | 4,704.5 | mil |
| Latest Shares Outstanding | 51.2 | mil |
| Earnings pS (EPS) | 3.82 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 1,238,901 | $ |
| Effective Tax Rate | 36.9 | % |
| Float | 41.8 | mil |
| Float as % of Shares Outstanding | 85.5 | % |
| Foreign Sales | - | |
| Domestic Sales | - | |
| Selling, General & Adm/tive (SG&A) as % of Revenue | - | |
| Research & Devlopment (R&D) as % of Revenue | - | |
| Gross Profit Margin | - | |
| EBITDA Margin | 3.1 | % |
| Pre-Tax Profit Margin | 2.6 | % |
| Assets Turnover | 2.9 | % |
| Return on Assets (ROA) | 4.2 | % |
| Return on Equity (ROE) | 9.1 | % |
| Return on Capital Invested (ROCI) | 6.8 | % |
| Current Ratio | - | |
| Leverage Ratio (Assets/Equity) | 2.2 | |
| Interest Cover | 6.4 | |
| Total Debt/Equity (Gearing Ratio) | 0.33 | |
| LT Debt/Total Capital | 25.0 | % |
| Working Capital pS | - | |
| Cash pS | - | |
| Book-Value pS | 27.87 | $ |
| Tangible Book-Value pS | 21.68 | $ |
| Cash Flow pS | 2.53 | $ |
| Free Cash Flow pS | 3.68 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 3.29 | |
| Price/Tangible Book Ratio | 4.23 | |
| Price/Cash Flow | 36.2 | |
| Price/Free Cash Flow | 24.9 | |
| P/E as % of Industry Group | 183.0 | % |
| P/E as % of Sector Segment | 272.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.0 | 101 | 11,672 | |
| 4 Weeks | 91.97 | 91.58 | 91.82 | -0.1 | 100 | 8,857 | 150,569 |
| 13 Weeks | 91.97 | 91.32 | 91.43 | 0.3 | 102 | 6,866 | 405,102 |
| 26 Weeks | 91.97 | 62.89 | 65.91 | 39.1 | 133 | 10,404 | 1,269,335 |
| 52 Weeks | 91.97 | 56.41 | 59.08 | 55.2 | 137 | 10,131 | 2,502,442 |
| YTD | 91.97 | 56.41 | - | 55.2 | 137 | 10,131 | 2,502,442 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 91.77 | 91.82 | 91.63 | 86.15 | 79.83 | 1.08 | 1.86 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 13.85 | 97.8 | 13.43 |
| Income | 0.00 | 0.0 | -1.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.00 | NA | 0.00 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 38.0 | 52.9 | 8.8 |
| Earnings % | -40.5 | -34.0 | -28.4 |
| EPS % | -40.1 | -35.4 | -29.3 |
| EPS $ | -1.26 | -0.34 | -1.58 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| |
| |
| |
| |
| FINANCIAL STRUCTURE RATIOS |
| Financial Leverage Ratio (Assets/Equity) | 2.18 |
| Debt Ratio | 54.15 |
| Total Debt/Equity (Gearing Ratio) | 0.51 |
| LT Debt/Equity | 0.31 |
| LT Debt/Capital Invested | 23.75 |
| LT Debt/Total Liabilities | 26.37 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.00 |
| Tobin's Q Ratio | 1.85 |
| Current P/E Ratio - LTM | 35.70 |
| Enterprise Value (EV)/EBITDA | 0.18 |
| Enterprise Value (EV)/Free Cash Flow | 18.64 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 4.23 |
| Price/Book Ratio - LTM | 3.29 |
| Price/Cash Flow Ratio | 36.2 |
| Price/Free Cash Flow Ratio - LTM | 24.9 |
| P/E Ratio (1 month ago) - LTM | 35.6 |
| P/E Ratio (26 weeks ago) - LTM | 21.2 |
| P/E Ratio (52 weeks ago) - LTM | 12.4 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 183.0 |
| P/E as % of Sector Segment | 272.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 35.7 |
| PER SHARE FIGURES |
| Tangible Book Value pS - LTM | 21.68 |
| Book Value pS - LTM | 27.87 |
| Capital Invested pS | 32.90 |
| Cash Flow pS - LTM | 2.53 |
| Free Cash Flow pS - LTM | 3.68 |
| Earnings pS (EPS) | 3.82 |
| | | | OPERATING RATIOS | | PROFITABILITY |
| Return on Equity (ROE) | 15.23 |
| Return on Equity (ROE) - 5YEAR AVRG. | 13.2 |
| Return on Capital Invested (ROCI) | 11.61 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 10.1 |
| Return on Assets (ROA) | 6.98 |
| Return on Assets (ROA) - 5YEAR AVRG. | 6.1 |
| EBIT Margin - LTM | 3.1 |
| EBITDA Margin - LTM | 3.1 |
| |
| |
| |
| |
| |
| |
| EFFICIENCY RATIOS |
| Revenue per Employee - LTM | 1,587,333 |
| Net Income per Employee - LTM | 25,415 |
| Assets/Revenue - LTM | 38.46 |
| |
|
|  
|
| |
 |  |
